Functional redundancy between the transcriptional activation domains of E2A is mediated by binding to the KIX domain of CBP/p300

Nucleic Acids Research

Volumn 42, Issue 11, 2014, Pages 7370-7382

  Denis, Christopher M ^a   Langelaan, David N ^a   Kirlin, Alyssa C ^a   Chitayat, Seth ^a   Munro, Kim ^a   Spencer, Holly L ^a   Lebrun, David P ^a,b   Smith, Steven P ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; TRANSCRIPTION FACTOR E2A; TRANSCRIPTION FACTOR PBX1;

ARTICLE; BINDING AFFINITY; BINDING SITE; CARCINOGENESIS; CELL IMMORTALIZATION; CONTROLLED STUDY; GENETIC CONSERVATION; HEMATOPOIETIC CELL; MUTAGENESIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN STRUCTURE; SEQUENCE ALIGNMENT; TRANSCRIPTION INITIATION;

BINDING SITES; BONE MARROW CELLS; MODELS, MOLECULAR; P300-CBP TRANSCRIPTION FACTORS; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN STRUCTURE, TERTIARY; TRANSCRIPTION FACTOR 3; TRANSCRIPTIONAL ACTIVATION;

EID: 84903178635     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gku206     Document Type: Article

References (71)

1. Bryder, D. and Sigvardsson, M. Bryder, D. and Sigvardsson, M. (2010) Shaping up a lineage-lessons from B lymphopoesis. Curr. Opin. Immunol., 22, 148-153.
2. Hesslein, D.G. and Lanier, L.L.Hesslein, D.G. and Lanier, L.L. (2011) Transcriptional control of natural killer cell development and function. Adv. Immunol., 109, 45-85.
3. Koch, U. and Radtke, F.Koch, U. and Radtke, F. (2011) Mechanisms of T cell development and transformation. Annu. Rev. Cell Dev. Biol., 27, 539-562.
4. Naito, T., Tanaka, H., Naoe, Y., and Taniuchi, I.Naito, T., Tanaka, H., Naoe, Y., and Taniuchi, I. (2011) Transcriptional control of T-cell development. Int. Immunol., 23, 661-668.
5. Nutt, S.L. and Kee, B.L.Nutt, S.L. and Kee, B.L. (2007) The transcriptional regulation of B cell lineage commitment. Immunity, 26, 715-725.
6. Ramirez, K. and Kee, B.L.Ramirez, K. and Kee, B.L. (2010) Multiple hats for natural killers. Curr. Opin. Immunol., 22, 193-198.
7. Santos, P., Arumemi, F., Park, K.S., Borghesi, L., and Milcarek, C.Santos, P., Arumemi, F., Park, K.S., Borghesi, L., and Milcarek, C. (2011) Transcriptional and epigenetic regulation of B cell development. Immunol. Res., 50, 105-112.
8. Braunstein, M. and Anderson, M.K. Braunstein, M. and Anderson, M.K. (2012) HEB in the spotlight: Transcriptional regulation of T-cell specification, commitment, and developmental plasticity. Clin. Dev. Immunol., 2012, 678705-678720.
9. de Pooter, R.F. and Kee, B.L.de Pooter, R.F. and Kee, B.L. (2010) E proteins and the regulation of early lymphocyte development. Immunol. Rev., 238, 93-109.
10. Kee, B.L. Kee, B.L. (2009) E and ID proteins branch out. Nat. Rev. Immunol., 9, 175-184.
11. Xu, W., Carr, T., Ramirez, K., McGregor, S., Sigvardsson, M., and Kee, B.L.Xu, W., Carr, T., Ramirez, K., McGregor, S., Sigvardsson, M., and Kee, B.L. (2013) E2A transcription factors limit expression of Gata3 to facilitate T lymphocyte lineage commitment. Blood, 121, 1534-1542.
12. Zhuang, Y., Soriano, P., and Weintraub, H.Zhuang, Y., Soriano, P., and Weintraub, H. (1994) The helix-loop-helix gene E2A is required for B cell formation. Cell, 79, 875-884.
13. Aronheim, A., Shiran, R., Rosen, A., and Walker, M.D.Aronheim, A., Shiran, R., Rosen, A., and Walker, M.D. (1993) The E2A gene product contains two separable and functionally distinct transcription activation domains. Proc. Natl. Acad. Sci. U.S.A., 90, 8063-8067.
14. Henthorn, P., Kiledjian, M., and Kadesch, T.Henthorn, P., Kiledjian, M., and Kadesch, T. (1990) Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science, 247, 467-470.
15. Hu, J.S., Olson, E.N., and Kingston, R.E.Hu, J.S., Olson, E.N., and Kingston, R.E. (1992) HEB, a helix-loop-helix protein related to E2A and ITF2 that can modulate the DNA-binding ability of myogenic regulatory factors. Mol. Cell. Biol., 12, 1031-1042.
16. Greenbaum, S. and Zhuang, Y.Greenbaum, S. and Zhuang, Y. (2002) Identification of E2A target genes in B lymphocyte development by using a gene tagging-based chromatin immunoprecipitation system. Proc. Natl. Acad. Sci. U.S.A., 99, 15030-15035.
17. Lin, Y.C., Jhunjhunwala, S., Benner, C., Heinz, S., Welinder, E., Mansson, R., Sigvardsson, M., Hagman, J., Espinoza, C.A., and Dutkowski, J. et al.Lin, Y.C., Jhunjhunwala, S., Benner, C., Heinz, S., Welinder, E., Mansson, R., Sigvardsson, M., Hagman, J., Espinoza, C.A., and Dutkowski, J. (2010) A global network of transcription factors, involving E2A, EBF1 and Foxo1, that orchestrates B cell fate. Nat. Immunol., 11, 635-643.
18. Massari, M.E. and Murre, C.Massari, M.E. and Murre, C. (2000) Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol. Cell. Biol., 20, 429-440.
19. Murre, C., McCaw, P.S., Vaessin, H., Caudy, M., Jan, L.Y., Jan, Y.N., Cabrera, C.V., Buskin, J.N., Hauschka, S.D., and Lassar, A.B. et al.Murre, C., McCaw, P.S., Vaessin, H., Caudy, M., Jan, L.Y., Jan, Y.N., Cabrera, C.V., Buskin, J.N., Hauschka, S.D., and Lassar, A.B. (1989) Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell, 58, 537-544.
20. Bayly, R., Chuen, L., Currie, R.A., Hyndman, B.D., Casselman, R., Blobel, G.A., and LeBrun, D.P.Bayly, R., Chuen, L., Currie, R.A., Hyndman, B.D., Casselman, R., Blobel, G.A., and LeBrun, D.P. (2004) E2A-PBX1 interacts directly with the KIX domain of CBP/p300 in the induction of proliferation in primary hematopoietic cells. J. Biol. Chem., 279, 55362-55371.
21. Bhalla, S., Spaulding, C., Brumbaugh, R.L., Zagort, D.E., Massari, M.E., Murre, C., and Kee, B.L.Bhalla, S., Spaulding, C., Brumbaugh, R.L., Zagort, D.E., Massari, M.E., Murre, C., and Kee, B.L. (2008) Differential roles for the E2A activation domains in B lymphocytes and macrophages. J. Immunol., 180, 1694-1703.
22. Bradney, C., Hjelmeland, M., Komatsu, Y., Yoshida, M., Yao, T.P., and Zhuang, Y.Bradney, C., Hjelmeland, M., Komatsu, Y., Yoshida, M., Yao, T.P., and Zhuang, Y. (2003) Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem., 278, 2370-2376.
23. Massari, M.E., Grant, P.A., Pray-Grant, M.G., Berger, S.L., Workman, J.L., and Murre, C.Massari, M.E., Grant, P.A., Pray-Grant, M.G., Berger, S.L., Workman, J.L., and Murre, C. (1999) A conserved motif present in a class of helix-loop-helix proteins activates transcription by direct recruitment of the SAGA complex. Mol. Cell, 4, 63-73.
24. Massari, M.E., Jennings, P.A., and Murre, C.Massari, M.E., Jennings, P.A., and Murre, C. (1996) The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol. Cell. Biol., 16, 121-129.
25. Quong, M.W., Massari, M.E., Zwart, R., and Murre, C.Quong, M.W., Massari, M.E., Zwart, R., and Murre, C. (1993) A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol. Cell. Biol., 13, 792-800.
26. Sepp, M., Kannike, K., Eesmaa, A., Urb, M., and Timmusk, T.Sepp, M., Kannike, K., Eesmaa, A., Urb, M., and Timmusk, T. (2011) Functional diversity of human basic helix-loop-helix transcription factor TCF4 isoforms generated by alternative 5' exon usage and splicing. PLoS One, 6, e22138.
27. Wang, F., Marshall, C.B., and Ikura, M.Wang, F., Marshall, C.B., and Ikura, M. (2013) Transcriptional/epigenetic regulator CBP/p300 in tumorigenesis: structural and functional versatility in target recognition. Cell. Mol. Life Sci, 70, 3989-4008.
28. Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T., and Roeder, R.G.Zhang, J., Kalkum, M., Yamamura, S., Chait, B.T., and Roeder, R.G. (2004) E protein silencing by the leukemogenic AML1-ETO fusion protein. Science, 305, 1286-1289.
29. Wang, D., Claus, C.L., Vaccarelli, G., Braunstein, M., Schmitt, T.M., Zuniga-Pflucker, J.C., Rothenberg, E.V., and Anderson, M.K.Wang, D., Claus, C.L., Vaccarelli, G., Braunstein, M., Schmitt, T.M., Zuniga-Pflucker, J.C., Rothenberg, E.V., and Anderson, M.K. (2006) The basic helix-loop-helix transcription factor HEBAlt is expressed in pro-T cells and enhances the generation of T cell precursors. J. Immunol., 177, 109-119.
30. Plevin, M.J., Mills, M.M., and Ikura, M.Plevin, M.J., Mills, M.M., and Ikura, M. (2005) The LxxLL motif: a multifunctional binding sequence in transcriptional regulation. Trends Biochem. Sci., 30, 66-69.
31. De Guzman, R.N., Goto, N.K., Dyson, H.J., and Wright, P.E.De Guzman, R.N., Goto, N.K., Dyson, H.J., and Wright, P.E. (2006) Structural basis for cooperative transcription factor binding to the CBP coactivator. J. Mol. Biol., 355, 1005-1013.
32. Denis, C.M., Chitayat, S., Plevin, M.J., Wang, F., Thompson, P., Liu, S., Spencer, H.L., Ikura, M., LeBrun, D.P., and Smith, S.P.Denis, C.M., Chitayat, S., Plevin, M.J., Wang, F., Thompson, P., Liu, S., Spencer, H.L., Ikura, M., LeBrun, D.P., and Smith, S.P. (2012) Structural basis of CBP/p300 recruitment in leukemia induction by E2A-PBX1. Blood, 120, 3968-3977.
33. Goto, N.K., Zor, T., Martinez-Yamout, M., Dyson, H.J., andWright, P.E.Goto, N.K., Zor, T., Martinez-Yamout, M., Dyson, H.J., and Wright, P.E. (2002) Cooperativity in transcription factor binding to the coactivator CREB-binding protein (CBP). The mixed lineage leukemia protein (MLL) activation domain binds to an allosteric site on the KIX domain. J. Biol. Chem., 277, 43168-43174.
34. Teufel, D.P., Freund, S.M., Bycroft, M., and Fersht, A.R.Teufel, D.P., Freund, S.M., Bycroft, M., and Fersht, A.R. (2007) Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc. Natl. Acad. Sci. U.S.A., 104, 7009-7014.
35. Wang, F., Marshall, C.B., Yamamoto, K., Li, G.Y., Gasmi-Seabrook, G.M., Okada, H., Mak, T.W., and Ikura, M.Wang, F., Marshall, C.B., Yamamoto, K., Li, G.Y., Gasmi-Seabrook, G.M., Okada, H., Mak, T.W., and Ikura, M. (2012) Structures of KIX domain of CBP in complex with two FOXO3a transactivation domains reveal promiscuity and plasticity in coactivator recruitment. Proc. Natl. Acad. Sci. U.S.A., 109, 6078-6083.
36. Bayly, R., Murase, T., Hyndman, B.D., Savage, R., Nurmohamed, S., Munro, K., Casselman, R., Smith, S.P., and LeBrun, D.P.Bayly, R., Murase, T., Hyndman, B.D., Savage, R., Nurmohamed, S., Munro, K., Casselman, R., Smith, S.P., and LeBrun, D.P. (2006) Critical role for a single leucine residue in leukemia induction by E2A-PBX1. Mol. Cell. Biol., 26, 6442-6452.
37. Hyndman, B.D., Thompson, P., Bayly, R., Cote, G.P., and LeBrun, D.P.Hyndman, B.D., Thompson, P., Bayly, R., Cote, G.P., and LeBrun, D.P. (2012) E2A proteins enhance the histone acetyltransferase activity of the transcriptional co-activators CBP and p300. Biochim. Biophys. Acta, 1819, 446-453.
38. Hyndman, B.D., Thompson, P., Denis, C.M., Chitayat, S., Bayly, R., Smith, S.P., and LeBrun, D.P.Hyndman, B.D., Thompson, P., Denis, C.M., Chitayat, S., Bayly, R., Smith, S.P., and LeBrun, D.P. (2012) Mapping acetylation sites in E2A identifies a conserved lysine residue in activation domain 1 that promotes CBP/p300 recruitment and transcriptional activation. Biochim. Biophys. Acta, 1819, 375-381.
39. Kamps, M.P.Kamps, M.P. (1997) E2A-Pbx1 induces growth, blocks differentiation, and interacts with other homeodomain proteins regulating normal differentiation. Curr. Topics Microbiol. Immunol., 220, 25-43.
40. Kamps, M.P. and Baltimore, D.Kamps, M.P. and Baltimore, D. (1993) E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol. Cell. Biol., 13, 351-357.
41. LeBrun, D.P.LeBrun, D.P. (2003) E2A basic helix-loop-helix transcription factors in human leukemia. Front. Biosci., 8, s206-s222.
42. Monica, K., LeBrun, D.P., Dedera, D.A., Brown, R., and Cleary, M.L.Monica, K., LeBrun, D.P., Dedera, D.A., Brown, R., and Cleary, M.L. (1994) Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol. Cell. Biol., 14, 8304-8314.
43. Farmer, B.T. II, Constantine, K.L., Goldfarb, V., Friedrichs, M.S., Wittekind, M., Yanchunas, J. Jr, Robertson, J.G., and Mueller, L.Farmer, B.T. II, Constantine, K.L., Goldfarb, V., Friedrichs, M.S., Wittekind, M., Yanchunas, J. Jr, Robertson, J.G., and Mueller, L. (1996) Localizing the NADP+ binding site on the MurB enzyme by NMR. Nat. Struct. Biol., 3, 995-997.
44. Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A.Delaglio, F., Grzesiek, S., Vuister, G.W., Zhu, G., Pfeifer, J., and Bax, A. (1995) NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR, 6, 277-293.
45. Johnson, B.A.Johnson, B.A. (2004) Using NMRView to visualize and analyze the NMR spectra of macromolecules. Methods Mol. Biol., 278, 313-352.
46. Simossis, V.A. and Heringa, J.Simossis, V.A. and Heringa, J. (2005) PRALINE: a multiple sequence alignment toolbox that integrates homology-extended and secondary structure information. Nucleic Acids Res., 33, W289-294.
47. Sali, A. and Blundell, T.L.Sali, A. and Blundell, T.L. (1993) Comparative protein modelling by satisfaction of spatial restraints. J. Mol. Biol., 234, 779-815.
48. DeLano, W.L.(8 March 2014, date last accessed)DeLano, W.L. (2009) In: DeLano Scientific, San Carlos, CA..
49. Scott, S.P., Teh, A., Peng, C., and Lavin, M.F.Scott, S.P., Teh, A., Peng, C., and Lavin, M.F. (2002) One-step site-directed mutagenesis of ATM cDNA in large (20kb) plasmid constructs. Hum. Mutat., 20, 323-327.
50. Lee, C.W., Arai, M., Martinez-Yamout, M.A., Dyson, H.J., and Wright, P.E.Lee, C.W., Arai, M., Martinez-Yamout, M.A., Dyson, H.J., and Wright, P.E. (2009) Mapping the interactions of the p53 transactivation domain with the KIX domain of CBP. Biochemistry, 48, 2115-2124.
51. Radhakrishnan, I., Perez-Alvarado, G.C., Parker, D., Dyson, H.J., Montminy, M.R., and Wright, P.E.Radhakrishnan, I., Perez-Alvarado, G.C., Parker, D., Dyson, H.J., Montminy, M.R., and Wright, P.E. (1997) Solution structure of the KIX domain of CBP bound to the transactivation domain of CREB: a model for activator:coactivator interactions. Cell, 91, 741-752.
52. Zor, T., De Guzman, R.N., Dyson, H.J., and Wright, P.E.Zor, T., De Guzman, R.N., Dyson, H.J., and Wright, P.E. (2004) Solution structure of the KIX domain of CBP bound to the transactivation domain of c-Myb. J. Mol. Biol., 337, 521-534.
53. Kasper, L.H., Boussouar, F., Ney, P.A., Jackson, C.W., Rehg, J., van Deursen, J.M., and Brindle, P.K.Kasper, L.H., Boussouar, F., Ney, P.A., Jackson, C.W., Rehg, J., van Deursen, J.M., and Brindle, P.K. (2002) A transcription-factor-binding surface of coactivator p300 is required for haematopoiesis. Nature, 419, 738-743.
54. Ramirez, J.A. and Nyborg, J.K.Ramirez, J.A. and Nyborg, J.K. (2007) Molecular characterization of HTLV-1 Tax interaction with the KIX domain of CBP/p300. J. Mol. Biol., 372, 958-969.
55. Campbell, K.M. and Lumb, K.J.Campbell, K.M. and Lumb, K.J. (2002) Structurally distinct modes of recognition of the KIX domain of CBP by Jun and CREB. Biochemistry, 41, 13956-13964.
56. Vendel, A.C., McBryant, S.J., and Lumb, K.J.Vendel, A.C., McBryant, S.J., and Lumb, K.J. (2003) KIX-mediated assembly of the CBP-CREB-HTLV-1 tax coactivator-activator complex. Biochemistry, 42, 12481-12487.
57. Kamps, M.P., Wright, D.D., and Lu, Q.Kamps, M.P., Wright, D.D., and Lu, Q. (1996) DNA-binding by oncoprotein E2a-Pbx1 is important for blocking differentiation but dispensable for fibroblast transformation. Oncogene, 12, 19-30.
58. Bruschweiler, S., Konrat, R., and Tollinger, M.Bruschweiler, S., Konrat, R., and Tollinger, M. (2013) Allosteric Communication in the KIX Domain Proceeds through Dynamic Repacking of the Hydrophobic Core. ACS Chem. Biol., 8, 1600-1610.
59. Feng, H., Jenkins, L.M., Durell, S.R., Hayashi, R., Mazur, S.J., Cherry, S., Tropea, J.E., Miller, M., Wlodawer, A., and Appella, E. et al.Feng, H., Jenkins, L.M., Durell, S.R., Hayashi, R., Mazur, S.J., Cherry, S., Tropea, J.E., Miller, M., Wlodawer, A., and Appella, E. (2009) Structural basis for p300 Taz2-p53 TAD1 binding and modulation by phosphorylation. Structure, 17, 202-210.
60. Jenkins, L.M., Yamaguchi, H., Hayashi, R., Cherry, S., Tropea, J.E., Miller, M., Wlodawer, A., Appella, E., and Mazur, S.J.Jenkins, L.M., Yamaguchi, H., Hayashi, R., Cherry, S., Tropea, J.E., Miller, M., Wlodawer, A., Appella, E., and Mazur, S.J. (2009) Two distinct motifs within the p53 transactivation domain bind to the Taz2 domain of p300 and are differentially affected by phosphorylation. Biochemistry, 48, 1244-1255.
61. Wells, M., Tidow, H., Rutherford, T.J., Markwick, P., Jensen, M.R., Mylonas, E., Svergun, D.I., Blackledge, M., and Fersht, A.R.Wells, M., Tidow, H., Rutherford, T.J., Markwick, P., Jensen, M.R., Mylonas, E., Svergun, D.I., Blackledge, M., and Fersht, A.R. (2008) Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. Proc. Natl. Acad. Sci. U.S.A., 105, 5762-5767.
62. Polley, S., Guha, S., Roy, N.S., Kar, S., Sakaguchi, K., Chuman, Y., Swaminathan, V., Kundu, T., and Roy, S.Polley, S., Guha, S., Roy, N.S., Kar, S., Sakaguchi, K., Chuman, Y., Swaminathan, V., Kundu, T., and Roy, S. (2008) Differential recognition of phosphorylated transactivation domains of p53 by different p300 domains. J. Mol. Biol., 376, 8-12.
63. Ferreon, J.C., Lee, C.W., Arai, M., Martinez-Yamout, M.A., Dyson, H.J., and Wright, P.E.Ferreon, J.C., Lee, C.W., Arai, M., Martinez-Yamout, M.A., Dyson, H.J., and Wright, P.E. (2009) Cooperative regulation of p53 by modulation of ternary complex formation with CBP/p300 and HDM2. Proc. Natl. Acad. Sci. U.S.A., 106, 6591-6596.
64. Teufel, D.P., Bycroft, M., and Fersht, A.R.Teufel, D.P., Bycroft, M., and Fersht, A.R. (2009) Regulation by phosphorylation of the relative affinities of the N-terminal transactivation domains of p53 for p300 domains and Mdm2. Oncogene, 28, 2112-2118.
65. King, A.M., Van der Put, E., Blomberg, B.B., and Riley, R.L.King, A.M., Van der Put, E., Blomberg, B.B., and Riley, R.L. (2007) Accelerated Notch-dependent degradation of E47 proteins in aged B cell precursors is associated with increased ERK MAPK activation. J. Immunol., 178, 3521-3529.
66. Lluis, F., Ballestar, E., Suelves, M., Esteller, M., and Munoz-Canoves, P.Lluis, F., Ballestar, E., Suelves, M., Esteller, M., and Munoz-Canoves, P. (2005) E47 phosphorylation by p38 MAPK promotes MyoD/E47 association and muscle-specific gene transcription. EMBO J., 24, 974-984.
67. Neufeld, B., Grosse-Wilde, A., Hoffmeyer, A., Jordan, B.W., Chen, P., Dinev, D., Ludwig, S., and Rapp, U.R.Neufeld, B., Grosse-Wilde, A., Hoffmeyer, A., Jordan, B.W., Chen, P., Dinev, D., Ludwig, S., and Rapp, U.R. (2000) Serine/Threonine kinases 3pK and MAPK-activated protein kinase 2 interact with the basic helix-loop-helix transcription factor E47 and repress its transcriptional activity. J. Biol. Chem., 275, 20239-20242.
68. Pedraza, N., Rafel, M., Navarro, I., Encinas, M., Aldea, M., and Gallego, C.Pedraza, N., Rafel, M., Navarro, I., Encinas, M., Aldea, M., and Gallego, C. (2009) Mixed lineage kinase phosphorylates transcription factor E47 and inhibits TrkB expression to link neuronal death and survival pathways. J. Biol. Chem., 284, 32980-32988.
69. Sloan, S.R., Shen, C.P., McCarrick-Walmsley, R., and Kadesch, T.Sloan, S.R., Shen, C.P., McCarrick-Walmsley, R., and Kadesch, T. (1996) Phosphorylation of E47 as a potential determinant of B-cell-specific activity. Mol. Cell. Biol., 16, 6900-6908.
70. Teachenor, R., Beck, K., Wright, L.Y., Shen, Z., Briggs, S.P., and Murre, C.Teachenor, R., Beck, K., Wright, L.Y., Shen, Z., Briggs, S.P., and Murre, C. (2012) Biochemical and phosphoproteomic analysis of the helix-loop-helix protein E47. Mol. Cell. Biol., 32, 1671-1682.
71. Visel, A., Rubin, E.M., and Pennacchio, L.A.Visel, A., Rubin, E.M., and Pennacchio, L.A. (2009) Genomic views of distant-acting enhancers. Nature, 461, 199-205.